Cargando…

Changes in m6A in Steatotic Liver Disease

Fatty liver disease is one of the major causes of morbidity and mortality worldwide. Fatty liver includes non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), now replaced by a consensus group as metabolic dysfunction-associated steatotic liver disease (MASLD). While e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petri, Belinda J., Cave, Matthew C., Klinge, Carolyn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454815/ https://www.ncbi.nlm.nih.gov/pubmed/37628704 http://dx.doi.org/10.3390/genes14081653

Ejemplares similares

Waiting for the changes after the adoption of steatotic liver disease
por: Yoon, Eileen L., et al.
Publicado: (2023)

The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017)

Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion
por: Jiménez-Castro, Mónica B., et al.
Publicado: (2019)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
por: Staufer, Katharina, et al.
Publicado: (2023)

How to Preserve Steatotic Liver Grafts for Transplantation
por: Patrono, Damiano, et al.
Publicado: (2023)

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
por: Huang, Gary, et al.
Publicado: (2023)

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts
por: Da, Ben L, et al.
Publicado: (2022)

Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers
por: Haq, Adeel, et al.
Publicado: (2023)

The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
por: Paklar, Natasa, et al.
Publicado: (2023)

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion
por: Mosbah, I Ben, et al.
Publicado: (2010)

Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients
por: Šeda, Ondrej, et al.
Publicado: (2019)

The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
por: Micó-Carnero, Marc, et al.
Publicado: (2022)

Integrating social nutrition principles into the treatment of steatotic liver disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2023)

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
por: Platek, Anna E., et al.
Publicado: (2023)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
por: Takahashi, Yoshihisa, et al.
Publicado: (2023)

The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023)

NO–IL-6/10–IL-1β axis: a new pathway in steatotic and non-steatotic liver grafts from brain-dead donor rats
por: Casillas-Ramírez, Araní, et al.
Publicado: (2023)

From Nonalcoholic Steatohepatits to Steatotic Liver Disease: A Long Way
por: Cotrim, Helma Pinchemel
Publicado: (2023)

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
por: Lasch, Alexandra, et al.
Publicado: (2021)

Ghrelin Restores the Disruption of the Circadian Clock in Steatotic Liver
por: Wang, Qin, et al.
Publicado: (2018)

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
por: Kim, Gi-Ae, et al.
Publicado: (2023)

Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts
por: Jadlowiec, Caroline, et al.
Publicado: (2020)

Double-lobectomy in a steatotic liver transplantation rat model
por: Fan, Lin, et al.
Publicado: (2021)

Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers
por: Basavarajappa, Lokesh, et al.
Publicado: (2021)

Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver
por: Klinge, Carolyn M, et al.
Publicado: (2021)

Role of Dietary Nutritional Treatment on Hepatic and Intestinal Damage in Transplantation with Steatotic and Non-Steatotic Liver Grafts from Brain Dead Donors
por: Micó-Carnero, Marc, et al.
Publicado: (2021)

Hepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver
por: Suzuki, Takeshi, et al.
Publicado: (2011)

Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice
por: Li, Shaowei, et al.
Publicado: (2017)

Niacin‐Induced Anicteric Microvesicular Steatotic Acute Liver Failure
por: Leung, Kenneth, et al.
Publicado: (2018)

Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
por: Nagai, Koki, et al.
Publicado: (2023)

Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
por: Wisse, Eddie, et al.
Publicado: (2021)

Epitranscriptomic Reader HNRNPA2B1 Confers Endocrine Resistance to Breast Cancer Cells
por: Klinge, Carolyn M, et al.
Publicado: (2021)

The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
por: Vesković, Milena, et al.
Publicado: (2023)

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
por: Kendall, Timothy J., et al.
Publicado: (2023)

S-Nitroso-N-Acetylcysteine Ameliorates Ischemia-Reperfusion Injury In The Steatotic Liver
por: Andraus, Wellington, et al.
Publicado: (2010)

Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
por: Zhu, Baoqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tlnjktj4p2pva08paq118ndo6d